Estimating the changing burden of disease attributable to high fasting plasma glucose in South Africa for 2000, 2006 and 2012
DOI:
https://doi.org/10.7196/SAMJ.2022.v112i8b.16659Keywords:
high fasting plasma glucose, burden of diseaseAbstract
Background. Worldwide, higher-than-optimal fasting plasma glucose (FPG) is among the leading modifiable risk factors associated with all- cause mortality and disability-adjusted life years (DALYs) due to the direct sequelae of diabetes and the increased risk for cardiovascular and chronic kidney disease.
Objectives. To report deaths and DALYs of health outcomes attributable to high FPG by age and sex for South Africa (SA) for 2000, 2006 and 2012.
Methods. Comparative risk assessment methodology was used to estimate the burden attributable to high FPG. A meta-regression analysis was performed using data from national and small-area studies to estimate the population distribution of FPG and diabetes prevalence. Attributable fractions were calculated for selected health outcomes and applied to local burden estimates from the second South African National Burden of Disease Study (SANBD2). Age-standardised rates were calculated using World Health Organization world standard population weights.
Results. We estimated a 5% increase in mean FPG from 5.31 (95% confidence interval (CI) 5.18 - 5.43) mmol/L to 5.57 (95% CI 5.41 - 5.72) mmol/L and a 75% increase in diabetes prevalence from 7.3% (95% CI 6.7 - 8.3) to 12.8% (95% CI 11.9 - 14.0) between 2000 and 2012. The age-standardised attributable death rate increased from 153.7 (95% CI 126.9 - 192.7) per 100 000 population in 2000 to 203.5 (95% CI 172.2 - 240.8) per 100 000 population in 2012, i.e. a 32.4% increase. During the same period, age-standardised attributable DALY rates increased by 43.8%, from 3 000 (95% CI 2 564 - 3 602) per 100 000 population in 2000 to 4 312 (95% CI 3 798 - 4 916) per 100 000 population in 2012. In each year, females had similar attributable death rates to males but higher DALY rates. A notable exception was tuberculosis, with an age-standardised attributable death rate in males double that in females in 2000 (14.3 v. 7.0 per 100 000 population) and 2.2 times higher in 2012 (18.4 v. 8.5 per 100 000 population). Similarly, attributable DALY rates were higher in males, 1.7 times higher in 2000 (323 v. 186 per 100 000 population) and 1.6 times higher in 2012 (502 v. 321 per 100 000 population). Between 2000 and 2012, the age-standardised death rate for chronic kidney disease increased by 98.3% (from 11.7 to 23.1 per 100 000 population) and the DALY rate increased by 116.9% (from 266 to 578 per 100 000 population).
Conclusion. High FPG is emerging as a public health crisis, with an attributable burden doubling between 2000 and 2012. The consequences are costly in terms of quality of life, ability to earn an income, and the economic and emotional burden on individuals and their families. Urgent action is needed to curb the increase and reduce the burden associated with this risk factor. National data on FPG distribution are scant, and efforts are warranted to ensure adequate monitoring of the effectiveness of the interventions.
References
Peykari N, Saeedi MS, Djalalinia S, et al. High fasting plasma glucose mortality effect: A comparative risk assessment in 25 - 64 years old Iranian population. Int J Prev Med 2016;7:75. https://doi. org/10.4103/2008-7802.182732
Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990 - 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380(9859):2224-2260. https://doi. org/10.1016/S0140-6736(12)61766-8
Jin C, Chen S, Vaidya A, et al. Longitudinal change in fasting blood glucose and myocardial infarction risk in a population without diabetes. Diabetes Care 2017;40(11):1565-1572. https://doi.org/10.2337/ dc17-0610
International Diabetes Federation. IDF Diabetes Atlas 9th edition. 2019. https://www.diabetesatlas. org/en/resources/ (accessed 14 December 2020).
Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas. Diabetes Res Clin Pract 2019;157:107843. https://doi.org/10.1016/j.diabres.2019.107843
Moradi-Lakeh M, Forouzanfar MH, El Bcheraoui C, et al. High fasting plasma glucose, diabetes, and its risk factors in the eastern Mediterranean region, 1990 - 2013: Findings from the Global Burden of Disease Study 2013. Diabetes Care 2017;40(1):22-29. https://doi.org/10.2337/dc16-1075
Norman R, Bradshaw D, Schneider M, et al. A comparative risk assessment for South Africa in 2000: Towards promoting health and preventing disease. S Afr Med J 2007;97(8):637-641.
Bradshaw D, Norman R, Pieterse D, et al. Estimating the burden of disease attributable to diabetes in South Africa in 2000. S Afr Med J 2007;97(8 Pt 2):700-706.
NationalDepartmentofHealth,SouthAfrica.Managementoftype2diabetesinadultsatprimarycare level. 2014. https://www.knowledgehub.org.za/system/files/elibdownloads/2019-07/Management%25 20of%2520ype%25202%2520Diabetes%2520%25202014.pdf (accessed 14 December 2021).
Pheiffer C. The prevalence of type 2 diabetes in South Africa: A systematic review. MPH thesis. Cape Town: University of Cape Town, 2020. http://hdl.handle.net/11427/32479 (accessed 15 December 2021).
Pheiffer C, Pillay-van Wyk V, Turawa E, et al. Prevalence of type 2 diabetes in South Africa: A systematic review and meta-analysis. Int J Environ Res Public Health 2021;18(11):5868. https://doi.
org/10.3390/ijerph18115868
GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990 - 2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018;392(10159):1923-1994. https://doi.org/10.1016/s0140-6736(18)32225-6
World Health Organization. Reducing risk, promoting healthy life. Geneva: WHO, 2002. http://www. who.int/whr/2002/en/summary_riskfactors_chp4.pdf (accessed 15 December 2020).
Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997;349(9063):1436-1442. https://doi.org/10.1016/S0140-6736(96)07495-8
Pillay-van Wyk V, Msemburi W, Laubscher R, et al. Mortality trends and differentials in South Africa from 1997 to 2012: Second National Burden of Disease Study. Lancet Glob Health 2016;4(9):e642-e653. https://doi.org/10.1016/S2214-109X(16)30113-9
World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: Report of a WHO consultation. Part 1: Diagnosis and classification of diabetes mellitus. Geneva: WHO, 1999. https://apps.who.int/iris/handle/10665/66040 (accessed 14 December 2020).
International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009;32(7):1327-1334. https://doi.org/10.2337/dc09-9033
Shisana O, Labadarios D, Rehle T, et al. The South African National Health and Nutrition Examination Survey, 2012: SANHANES-1: The health and nutritional status of the nation. 2014. http://repository. hsrc.ac.za/handle/20.500.11910/2864 (accessed 22 December 2020).
National Department of Health, Statistics South Africa, South African Medical Research Council and ICF. South Africa Demographic and Health Survey 2016. Pretoria: NDoH, 2019. http://dhsprogram. com/pubs/pdf/FR337/FR337.pdf (accessed 21 December 2020).
Omar MAK, Seedat M, Motala A, et al. The prevalence of diabetes mellitus and impaired glucose tolerance in a group of urban South African blacks. S Afr Med J 1993;83(9):641-643.
Levitt NS, Katzenellenbogen JM, Bradshaw D, et al. The prevalence and identification of risk factors for NIDDM in urban Africans in Cape Town, South Africa. Diabetes Care 1993;16(4):601-607. https:// doi.org/10.2337/diacare.16.4.601
Omar MA, Seedat MA, Dyer RB, et al. South African Indians show a high prevalence of NIDDM and bimodality in plasma glucose distribution patterns. Diabetes Care 1994;17(1):70-73. https://doi. org/10.2337/diacare.17.1.70
Mollentze W, Moore A, Steyn A, et al. Coronary heart disease risk factors in a rural and urban Orange Free State black population. S Afr Med J 1995;85(2):90-96.
Levitt NS, Steyn K, Lambert EV, et al. Modifiable risk factors for type 2 diabetes mellitus in a peri- urban community in South Africa. Diabet Med 1999;16(11):946-950. https://doi.org/10.1046/j.1464- 5491.1999.00185.x
Motala AA, Esterhuizen T, Gouws E, et al. Diabetes and other disorders of glycemia in a rural South African community: Prevalence and associated risk factors. Diabetes Care 2008;31(9):1783-1788. https:// doi.org/10.2337/dc08-0212
Peer N, Steyn K, Lombard C, et al. Rising diabetes prevalence among urban-dwelling black South Africans. PLoS ONE 2012;7(9):e43336. https://doi.org/10.1371/journal.pone.0043336
Hird TR, Pirie FJ, Esterhuizen TM, et al. Burden of diabetes and first evidence for the utility of HbA1c for diagnosis and detection of diabetes in urban black South Africans: The Durban Diabetes Study. PLoS ONE 2016;11(8):e0161966. https://doi.org/10.1371/journal.pone.0161966
Zemlin AE, Barkhuizen M, Kengne AP, et al. Performance of glycated albumin for type 2 diabetes and prediabetes diagnosis in a South African population. Clin Chim Acta 2019;488:122-128. https://doi. org/10.1016/j.cca.2018.11.005
Gelman A, Carlin JB, Stern HS, et al. Bayesian Data Analysis. 2nd ed. London: Chapman & Hall, 2004.
Holland S. Transformations of proportions and percentages. http://strata.uga.edu/8370/rtips/ proportions.html (accessed 14 December 2020).
Dorrington R. Alternative South African mid-year estimates, 2013. Cape Town: Centre for Actuarial Research, University of Cape Town, 2013. http://www.care.uct.ac.za/sites/default/files/image_tool/ images/561/Downloads/Mono11.pdf (accessed 22 December 2020).
Danaei G, Finucane MM, Lu Y, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: Systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 2011;378(9785):31-40. https://doi.org/10.1016/s0140-6736(11)60679-x
Ahmad OB, Boschi-Pinto C, Lopez AD, et al. Age standardisation of rates: A new WHO standard. Geneva: World Health Organization, 2001. https://www.researchgate.net/publication/284696312_ Age_Standardization_of_Rates_A_New_WHO_Standard (accessed 20 December 2020).
Barendregt JJ. The effect size in uncertainty analysis. Value Health 2010;13(4):388-391. https://doi. org/10.1111/j.1524-4733.2009.00686.x
NCDRiskFactorCollaboration–AfricaWorkingGroup.TrendsinobesityanddiabetesacrossAfrica from 1980 to 2014: An analysis of pooled population-based studies. Int J Epidemiol 2017;46(5):1421- 1432. https://doi.org/10.1093/ije/dyx078
Hilawe EH, Yatsuya H, Kawaguchi L, et al. Differences by sex in the prevalence of diabetes mellitus, impaired fasting glycaemia and impaired glucose tolerance in sub-Saharan Africa: A systematic review and meta-analysis. Bull World Health Organ 2013;91(9):671-682D. https://doi.org/10.2471/ BLT.12.113415
Kautzky-Willer A, Harreiter J, Pacini G. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocr Rev 2016;37(3):278-316. https://doi.org/10.1210/ er.2015-1137
GoedeckeJH,MtintsilanaA,DlaminiSN,etal.Type2diabetesmellitusinAfricanwomen.Diabetes Res Clin Pract 2017;123:87-96. https://doi.org/10.1016/j.diabres.2016.11.017
Belkina AC, Denis GV. Obesity genes and insulin resistance. Curr Opin Endocrinol Diabetes Obes 2010;17(5):472-477. https://doi.org/10.1097/MED.0b013e32833c5c48
Wu Y, Ding Y, Tanaka Y, et al. Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention. Int J Med Sci 2014;11(11):1185-200. https://doi.org/10.7150/ijms.10001
Sanada H, Yokokawa H, Yoneda M, et al. High body mass index is an important risk factor for the development of type 2 diabetes. Intern Med 2012;51(14):1821-1826. https://doi.org/10.2169/ internalmedicine.51.7410
Cois A, Day C. Obesity trends and risk factors in the South African adult population. BMC Obes 2015;2:42. https://doi.org/10.1186/s40608-015-0072-2
Dorrington R, Bradshaw D, Laubscher R, et al. Rapid mortality surveillance report 2012. Cape Town: South African Medical Research Council, 2014. www.mrc.ac.za/bod/reports.htm (accessed 22 December 2020)
Galdas PM, Cheater F, Marshall P. Men and health help‐seeking behaviour: Literature review. J Adv Nurs 2005;49(6):616-623. https://doi.org/10.1111/j.1365-2648.2004.03331.x
Kyu HH, Maddison ER, Henry NJ, et al. The global burden of tuberculosis: Results from the Global Burden of Disease Study 2015. Lancet Infect Dis 2018;18(3):261-284. https://doi.org/10.1016/S1473- 3099(17)30703-X
World Health Organization. Global tuberculosis report. Geneva: WHO, 2018. https://apps.who.int/ iris/bitstream/handle/10665/274453/9789241565646-eng.pdf (accessed 12 December 2020).
Davids MR, Jardine T, Marais N, et al. South African Renal Registry Annual Report 2017. Afr J Nephrol 2019;22(1):60-71. https://doi.org/10.21804/22-1-3810
Ekoru K, Doumatey A, Bentley AR, et al. Type 2 diabetes complications and comorbidity in Sub- Saharan Africans. EClinicalMedicine 2019;16:30-41. https://doi.org/10.1016/j.eclinm.2019.09.001 49. AtunR,DaviesJI,GaleEAM,etal.Diabetesinsub-SaharanAfrica:Fromclinicalcaretohealthpolicy.
Lancet Diabetes Endocrinol 2017;5(8):622-667. https://doi.org/10.1016/S2213-8587(17)30181-X
Hill J, Lavigne Delville C, Auorousseau AM, et al. Development of a tool to increase physical activity among people at risk for diabetes in low-resourced communities in Cape Town. Int J Environ Res
Public Health 2020;17(3):865. https://doi.org/10.3390/ijerph17030865
Stokes A, Berry KM, Mchiza Z, et al. Prevalence and unmet need for diabetes care across the care
continuum in a national sample of South African adults: Evidence from the SANHANES-1, 2011 -
PloS ONE 2017;12(10):e0184264. https://doi.org/10.1371/journal.pone.0184264
Kengne AP, Erasmus RT, Levitt NS, et al. Alternative indices of glucose homeostasis as biochemical diagnostic tests for abnormal glucose tolerance in an African setting. Prim Care Diab 2017;11(2):119-
https://doi.org/10.1016/j.pcd.2017.01.004
Ndinda C, Ndhlovu TP, Juma P, et al. The evolution of non-communicable diseases policies in post-
apartheid South Africa. BMC Public Health 2018;18(Suppl 1):956. https://doi.org/10.1186/s12889-
-5832-8
National Department of Health, South Africa. National Strategic Plan for the Prevention and Control of Non-communicable Diseases 2020 - 2025. 2019. https://www.sancda.org.za/wp-content/ uploads/2020/05/17-May-2020-South-Africa-NCD-STRATEGIC-PLAN_For-Circulation.pdf (accessed 4 June 2022).
Juma PA, Mapa-Tassou C, Mohamed SF, et al. Multi-sectoral action in non-communicable disease prevention policy development in five African countries. BMC Public Health 2018;18(Suppl 1):953. https://doi.org/10.1186/s12889-018-5826-6
DepartmentofSportandRecreation,SouthAfrica.NationalRecreationDay.2014.https://www.srsa. gov.za/content/national-recreation-day (accessed 22 December 2020).
Department of Sport and Recreation, South Africa. The Big Walk. 2012. https://www.srsa.gov.za/ content/big-walk (accessed 22 December 2020).
South African Government. The Move for Health Day. https://www.gov.za/world-move-health-day (accessed 22 December 2020).
Department of Basic Education, South Africa. National School Nutrition Programme. https://www. education.gov.za/Programmes/NationalSchoolNutritionProgramme.aspx (accessed 22 December 2020).
Western Cape Government. Western Cape on Wellness. https://www.westerncape.gov.za/ westerncape-on-wellness/about-us (accessed 22 December 2020).
Lambert EV, Kolbe-Alexander TL. Innovative strategies targeting obesity and non-communicable diseases in South Africa: What can we learn from the private healthcare sector? Obesity Rev 2013;14(Suppl 2):141-149. https://doi.org/10.1111/obr.12094
BoulleA,DaviesMA,HusseyH,etal.RiskfactorsforCOVID-19deathinapopulationcohortstudy from the Western Cape Province, South Africa. Clin Infect Dis 2021;73(7):e2005-e2015. https://doi. org/10.1093/cid/ciaa1198
Pillay-van Wyk V, Bradshaw D, Groenewald P, et al. COVID-19 deaths in South Africa: 99 days since South Africa’s first death. S Afr Med J 2020;110(11):1093-1099. https://doi.org/10.7196/SAMJ.2020. v110i11.15249
Patel P, Rose CE, Collins PY, et al. Noncommunicable diseases among HIV-infected persons in low- income and middle-income countries: A systematic review and meta-analysis. AIDS 2018;32 (Suppl 1):S5-S20. https://doi.org/10.1097/QAD.0000000000001888
Nansseu JR, Bigna JJ, Kaze AD, et al. Incidence and risk factors for prediabetes and diabetes mellitus among HIV-infected adults on antiretroviral therapy: A systematic review and meta-analysis. Epidemiology 2018;29(3):431-441. https://doi.org/10.1097/EDE.0000000000000815
Njuguna B, Kiplagat J, Bloomfield GS, et al. Prevalence, risk factors, and pathophysiology of dysglycemia among people living with HIV in sub-Saharan Africa. J Diabetes Res 2018;2018:6916497. https://doi.org/10.1155/2018/6916497
Prioreschi A, Munthali RJ, Soepnel L, et al. Incidence and prevalence of type 2 diabetes mellitus with HIV infection in Africa: A systematic review and meta-analysis. BMJ Open 2017;7(3):e013953. https:// doi.org/10.1136/bmjopen-2016-013953
Erzse A, Stacey N, Chola L, et al. The direct medical cost of type 2 diabetes mellitus in South Africa: A cost of illness study. Glob Health Action 2019;12(1):1636611. https://doi.org/10.1080/16549716.2019.1636611
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Licensing Information
The SAMJ is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
Publishing Rights
Authors grant the Publisher the exclusive right to publish, display, reproduce and/or distribute the Work in print and electronic format and in any medium known or hereafter developed, including for commercial use. The Author also agrees that the Publisher may retain in print or electronic format more than one copy of the Work for the purpose of preservation, security and back-up.